Ibandronate Sodium CAS:138844-81-2 Umhlinzeki Womkhiqizi
I-ibandronate sodium isetshenziswe ukutadisha umphumela wayo ekwandeni nasekuhlelekeni okukhulu kweLeishmania neGiardia ngokukhiqiza ama-concentration curves. Isetshenziswe futhi ukucacisa indlela ama-bisphosphonates aqukethe i-nitrogen (N-BPs) angena ngayo ku-cytosol futhi avimbele umgomo wawo wama-molecule. I-ibandronate sodium ivimbela i-farnesyl diphosphate synthase (IC50 = 20 nM). I-ibandronate sodium nayo iyisithiyo sokuphinda kufakwe amathambo. Ihlolisiswe ngemiphumela yokulwa nomdlavuza ngaphakathi kwe-vitro, njengokungeniswa kwe-apoptosis, ukuvimbela ukukhula kwamaseli, ukuvimbela ukuziphatha okuhlaselayo, kanye nokuvimbela i-angiogenesis kanye nendima yayo ngaphakathi kwe-vivo kumdlavuza ohlukahlukene okuhlanganisa umdlavuza webele nowe-prostate.
| Ukwakheka | I-C9H24NNaO7P2 |
| Ukuhlolwa | 99% |
| Ukubukeka | Impuphu emhlophe |
| Inombolo ye-CAS | 138844-81-2 |
| Ukupakisha | 25KG |
| Impilo Yeshelufu | iminyaka engu-2 |
| Isitoreji | Gcina endaweni epholile neyomile |
| Isitifiketi | I-ISO. |








